NORTON SOUND REGIONAL HOSPITAL
1. Target Overview & Investment Thesis
NORTON SOUND REGIONAL HOSPITAL is a 18-bed safety-net/medicaid heavy in NOME BOROUGH, AK with $148.7M in net patient revenue and a -28.6% operating margin. The hospital serves a payer mix of 34.2% Medicare, 46.0% Medicaid, and 19.7% commercial.
Thesis: Turnaround. Our ML models identify $10.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -28.6% to -21.3% (+736bps).
| Net Revenue HCRIS | $148.7M |
| Current EBITDA COMPUTED | $-42.6M |
| Operating Margin COMPUTED | -28.6% |
| Occupancy HCRIS | 61.0% |
| Revenue / Bed COMPUTED | $8.3M |
| Net-to-Gross HCRIS | 77.4% |
| Distress Probability ML | 50.9% |
2. Market Context & Competitive Position
AK has 24 Medicare-certified hospitals with a median operating margin of -2.1%. The target's margin of -28.6% places it below the state median. Among 12 size-comparable peers (9-36 beds), the median margin is -8.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (9-36), prioritizing same-state peers. 12 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| NORTON SOUND REGIONAL HOSPITAL (Target) | AK | 18 | $148.7M | -28.6% |
| SOUTH PENINSULA HOSPITAL | AK | 21 | $112.1M | -3.4% |
| KETCHIKAN MEDICAL CENTER | AK | 25 | $92.4M | -13.1% |
| PROV. KODIAK ISLAND MEDICAL CE | AK | 24 | $59.6M | -0.6% |
| SAMUEL SIMMONDS MEMORIAL HOSPI | AK | 10 | $57.8M | -50.0% |
| ALASKA SPECIALTY HOSPITAL LLC | AK | 26 | $38.7M | -29.0% |
| PROVIDENCE VALDEZ MEDICAL CENT | AK | 11 | $20.0M | 8.4% |
| PETERSBURG MEDICAL CENTER | AK | 12 | $19.5M | -10.7% |
| CORDOVA COMMUNITY MEDICAL CENT | AK | 13 | $12.3M | -5.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $95K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-42.6M |
| + RCM Uplift | +$10.9M |
| Pro Forma EBITDA | $-31.6M |
| Current Margin | -28.6% |
| Pro Forma Margin | -21.3% |
| WC Released (1x) | $5.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-65.5M | $-171.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-65.5M | $-209.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-58.9M | $-194.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-58.9M | $-230.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-72.0M | $-204.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-72.0M | $-248.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (46.0%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 50.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 12 hospitals with 9-36 beds
- Same-state prioritization (n=13)
- Comp margins: P25=-17.1% / P50=-8.1% / P75=-2.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.